Date

Monday, 18 May 2020

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Agenda - COMP agenda of the 18-20 May 2020 meeting

COMP meeting report on the review of applications for orphan designation: May 2020

Minutes of the COMP meeting 18-20 May 2020

How useful do you find this page?